Cianna Medical Reports Highly Favorable Data on Its Breast Cancer Surgical Guidance System at ASBrS Meeting

Cianna Medical Reports Highly Favorable Data on Its Breast Cancer Surgical Guidance System at ASBrS Meeting
Cianna Medical, Inc. announced the presentation of clinical results showing that SAVI SCOUT, its breast localization and surgical guidance system, has a perfect success rate, high clinical reproducibility, and favorable levels of clinician and patient satisfaction. The presentation was given by Dr.  Pat Whitworth, a breast surgeon and study investigator, at the 17th Annual Meeting of American Society of Breast Surgeon (ASBrS) held April 13–17 in Dallas, Texas. SAVI SCOUT is an U.S. Food and Drug Administration (FDA)-approved guidance system for the removal of non-palpable breast lesions. It uses non-radioactive, electromagnetic wave technology to detect a reflector placed in the target tissue up to seven days prior to surgery. Results from a pilot study, evaluating the placement, localization, and retrieval of targeted lesions and reflectors in 154 patients, showed a 100 percent surgical success rate, as well as lower rates of repeat surgery compared to the use of wire localization. In all clinical cases, targeted lesions and reflectors were effectively removed without any reflector migration. High clinician and patient satisfaction were also reported. On a 1-5 scale, with 3 being equivalent to wire localization, surgeons positively rated the system for an ability to begin cases earlier at 4.9, and at 4.3 for a reduction in surgical scheduling delays. Likewise, radiologists rated patient comfort, anxiety, and overall experience higher than wire localization, at 3.7, 3.8, and 4.1, respectively. Results from a post-procedure survey also found that 97 percent of patien
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.